Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Cigarette smoke extract-mediated FABP4 upregulation suppresses viability and induces apoptosis, inflammation and oxidative stress of bronchial epithelial cells by activating p38 MAPK/MK2 signaling pathway. | J Inflamm (Lond) | 2022 | 35706027 | PubTator, text mining | PubMed |
| Can natural products modulate cytokine storm in SARS-CoV2 patients? | Biotechnol Rep (Amst) | 2022 | 35702395 | PubTator, text mining | PubMed |
| Differing coronavirus genres alter shared host signaling pathways upon viral infection. | Sci Rep | 2022 | 35697915 | PubTator, text mining | PubMed |
| Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner. | PeerJ | 2022 | 35694386 | PubTator, text mining | PubMed |
| Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders. | Transl Res | 2022 | 35691544 | PubTator, text mining | PubMed |
| Signature for Pain Recovery IN Teens (SPRINT): protocol for a multisite prospective signature study in chronic musculoskeletal pain. | BMJ Open | 2022 | 35676017 | PubTator, text mining | PubMed |
| Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. | Acta Histochem | 2022 | 35662001 | PubTator, text mining | PubMed |
| The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma. | Transl Oncol | 2022 | 35660848 | PubTator, text mining | PubMed |
| Global characterization of megakaryocytes in bone marrow, peripheral blood, and cord blood by single-cell RNA sequencing. | Cancer Gene Ther | 2022 | 35650393 | PubTator, text mining | PubMed |
| The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities. | Cell Biosci | 2022 | 35642067 | PubTator, text mining | PubMed |
| Gamma synuclein promotes cancer metastasis through the MKK3/6-p38MAPK cascade. | Int J Biol Sci | 2022 | 35637967 | PubTator, text mining | PubMed |
| PARP Inhibition and Beyond in BRCA-Associated Breast Cancer in Women: A State-Of-The-Art Summary of Preclinical Research on Risk Reduction and Clinical Benefits. | Med Princ Pract | 2022 | 35636395 | PubTator, text mining | PubMed |
| Targeting MAPK in Cancer 2.0. | Int J Mol Sci | 2022 | 35628511 | PubTator, text mining | PubMed |
| Small Molecule Arranged Thermal Proximity Coaggregation (smarTPCA)-A Novel Approach to Characterize Protein-Protein Interactions in Living Cells by Similar Isothermal Dose-Responses. | Int J Mol Sci | 2022 | 35628420 | PubTator, text mining | PubMed |
| Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms. | Diagnostics (Basel) | 2022 | 35626397 | PubTator, text mining | PubMed |
| Diagnostics of HNSCC Patients: An Analysis of Cell Lines and Patient-Derived Xenograft Models for Personalized Therapeutical Medicine. | Diagnostics (Basel) | 2022 | 35626227 | PubTator, text mining | PubMed |
| Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin. | Biomedicines | 2022 | 35625926 | PubTator, text mining | PubMed |
| Cross-Talk between Wnt Signaling and Src Tyrosine Kinase. | Biomedicines | 2022 | 35625853 | PubTator, text mining | PubMed |
| The Developmental Transcription Factor p63 Is Redeployed to Drive Allergic Skin Inflammation through Phosphorylation by p38α. | J Immunol | 2022 | 35623662 | PubTator, text mining | PubMed |
| What protein kinases are crucial for acantholysis and blister formation in pemphigus vulgaris? A systematic review. | J Cell Physiol | 2022 | 35616233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=28